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TECHNICAL NOTES
Cutting balloon angioplasty of resistant renal
artery stenosis caused by fibromuscular dysplasia
Masayuki Tanemoto, MD, PhD,a Takaaki Abe, MD, PhD,a,c Tatsuji Chaki, MD,a
Fumitoshi Satoh, MD, PhD,a Tadashi Ishibashi, MD, PhD,b and Sadayoshi Ito, MD, PhD,a Sendai,
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Balloon angioplasty is an established intervention to treat renovascular hypertension. Conventional balloon angioplasty
is usually effective in cases of renovascular hypertension caused by fibromuscular dysplasia. In the present report, we
describe two cases of renovascular hypertension caused by fibromuscular dysplasia in which stenotic lesions were resistant
to conventional balloon angioplasty but were successfully managed by a cutting balloon. After cutting balloon
angioplasty, systemic blood pressure was normalized in both patients, without the use of antihypertensive agents.
Angioplasty by using a cutting balloon is a new therapeutic choice against renal artery stenosis that is resistant to dilation
by a conventional balloon. (J Vasc Surg 2005;41:898-901.)Renovascular hypertension is a curable form of hyper-
tension often caused by renal artery stenosis (RAS). Ath-
erosclerosis and fibromuscular dysplasia are the two major
causes of RAS.1Atherosclerotic RAS is usually seen in the
elderly, and the lesions are localized at proximal portions of
the renal artery, including ostium. Fibromuscular dysplasia
is usually seen in the young and affects more distal portions
of the renal artery. In both cases, revascularization of RAS is
the primary measure to treat renovascular hypertension.
Because of its less invasive nature, percutaneous trans-
luminal renal angioplasty (PTRA) with a conventional bal-
loon catheter has become the primary choice of revascular-
ization, especially in cases caused by fibromuscular
dysplasia. Some stenotic lesions are resistant to revascular-
ization by PTRA, however, and stent-placement with
PTRA (stenting) is performed to overcome such resis-
tance.2 Stenting has improved initial patency rate compared
with PTRA alone, but in-stent restenosis, which is difficult
to recanalize, can occur.3 Because the incidence of in-stent
restenosis is high in cases with insufficient dilation before
stent placement, a new therapeutic modality to attain suf-
ficient dilation is required to obtain long-term patency.4
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898A cutting balloon that has three to four longitudinal
blades mounted on the outer surface is a new device for
angioplasty that was developed to dilate in-stent restenosis
or resistant stenotic lesions of the coronary artery.5 In the
present report, we describe two cases of resistant RAS that
was successfully dilated by a cutting balloon. A sustained
normotensive state6months after the procedure demon-
strates the usefulness of the cutting balloon to dilate RAS
that is resistant to PTRA.
CASE REPORTS
Patient 1. A 16-year-old boy was found to be hypertensive
(160/100 mm Hg), when he consulted at another hospital for
severe headache. RAS was found with magnetic resonance angiog-
raphy, and the patient was suspected to have renovascular hyper-
tension. Renal arteriography confirmed focal RAS at the middle
portion of right main trunk, a characteristic image of intimal-type
fibromuscular dysplasia (Fig 1, A). The RAS could not be suffi-
ciently dilated by PTRA, so he was referred to our hospital for
further treatment of residual RAS.
An oblique arteriography view showed a segmental stenosis
from the main trunk to the bifurcation of the first branches of right
renal artery, and the mean pressure gradient was 27 mmHg across
the stenosis (Fig 1, B). PTRA did dilate the RAS in the first
branches but not in the main trunk, even with a 5.5-mm-diameter
balloon at an inflation pressure of 16 atm (Fig 1, C). A single
inflation with a 5.0 mm-diameter cutting balloon (Boston Scien-
tific, Natick, Mass) successfully dilated the residual RAS at 6 atm
(Fig 1, D inset). An additional dilation with a 5.5-mm-diameter
conventional balloon did not show any “waist,” even at 6 atm, and
there was no pressure gradient at the site of RAS. Repeated
angiography confirmed patency of the right renal artery (Fig 1, D).
Systemic blood pressure was soon normalized to 110/70 mmHg,
and at 6 months after the procedure, it remained normal.
raph
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Volume 41, Number 5 Tanemoto et al 899Patient 2. A 21-year-old woman was referred to our hospital
for the evaluation of juvenile hypertension that was not controlled
sufficiently (145/100 mmHg) even with the administration of a
calcium-channel antagonist. Renal arteriography found a focal
RAS at the middle portion of right main trunk, a characteristic
image of intimal-type fibromuscular dysplasia (Fig 2, A). Systemic
blood pressure was reduced immediately after PTRA but increased
gradually thereafter, which indicated an occurrence of restenosis.
The second angiography confirmed RAS at the site of the initial
PTRA and there was a mean pressure gradient of 20 mmHg across
the stenosis (Fig 2, B). Although PTRA with a 5.5-mm-diameter
balloon at inflation pressure of 16 atm could not dilate the RAS
sufficiently (Fig 2, C), a single inflation with a 5.0-mm-diameter
cutting balloon dilated the residual RAS at 10 atm (Fig 2, D inset).
Repeated angiography detected a lesion of intimal dissection
Fig 1. Right renal arteriography of patient 1. A, A 90%
of the main trunk. B, RAS, which was more prominentl
percutaneous transluminal renal angioplasty (PTRA). C
pressure (inset), and RAS was not sufficiently dilated.D,
and sufficient patency was confirmed by repeated angiogat the site of dilation (Fig 2, D), however, so we did not perform afurther procedure. No apparent signs of aneurysmal formation,
intimal flaps, or restenosis were detected by computed tomo-
graphic angiography 2 weeks after the procedure. The patient’s
systemic blood pressure was soon normalized and remained nor-
mal at 6 months after the procedure.
DISCUSSION
In the present report, we described two cases of RAS
caused by fibromuscular dysplasia that were resistant to
dilation by PTRA. Among three histologic types of fibro-
muscular dysplasia, the intimal type is considered to be
more difficult to dilate than the medial or perimedial types.
Intimal-type fibromuscular dysplasia was therefore the
likely underlying abnormality in both patients. Although
artery stenosis (RAS) was detected at the middle portion
by an oblique view (inset), still remained after the first
waist” was seen during PTRA even with high inflation
waist disappeared by cutting balloon angioplasty (inset),
y.renal
y seen
, A “
Thewe could not confirm it histologically, the angiographic
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the artery) supports this notion.
A conventional balloon tears stenotic arterial wall,
whereas the cutting balloon creates incisions by its blades
and can dilate resistant stenosis. The rigidity of the blades
may cause adverse side effects, however, including dissec-
tion of arterial wall.6-8 To avoid such side effects, the
cutting balloon should only be used at an artery with a
sufficiently straight portion for the length of balloon, and a
cutting balloon with a relatively undersized diameter
should be used to make the initial incisions, followed by
dilation with a conventional balloon.7,9 Although we used
an undersized cutting balloon on the relatively straight
portion of the renal artery, intimal dissection occurred in
patient 2. Fortunately, the dissection healed without appar-
ent signs of aneurysmal formation or restenosis during an
Fig 2. Right renal arteriography of patient 2. A, A 75%
of the main trunk, which was successfully dilated by fi
Several years after the first PTRA, 50% RAS was seen at th
even with a high inflation pressure (inset), and RAS remai
(inset), and sufficient patency was obtained, although aadministration of low-dose aspirin.Perforation of the renal artery is one of the most serious
adverse side effects of PTRA, and the incidence of this side
effect is reported to be higher in fibromuscular dysplasia than
in atherosclerotic lesions. The reason has not been clarified,
but the higher inflation pressure needed for angioplasty and
irregularities of the arterial wall thickness are thought to be
responsible. Precise placement of the balloon with the aid of
intravascular ultrasound imaging, especially in the case of the
cutting balloon, would reduce the incidence.6,10
To perform cutting balloon angioplasty, we had to place a
sheath with a larger diameter (2.3 mm vs 1.6 mm for conven-
tional PTRA) in the femoral artery. The use of a larger size
sheath could increase the possible side effects of hematoma
andpseudoaneurysm formation at the site of arterial puncture,
but we did not experience any of these adverse effects.
In summary, we presented two cases of renovascular hy-
artery stenosis (RAS) was detected at the middle portion
rcutaneous transluminal renal angioplasty (PTRA). B,
e site of initial RAS.C, A “waist” was seen during PTRA,
D) The waist disappeared by cutting balloon angioplasty
dissection occurred.renal
rst pe
e sam
ned. (pertension causedbyRAS thatwas resistant toPTRA.Cutting
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tant RAS without restenosis for 6 months after the proce-
dure. Cutting balloon angioplasty could thus be considered as
a therapeutic choice to achieve sufficient dilatation in cases of
resistant RAS. Although the use of cutting balloon for RAS
was safe and effective, further studies are needed to establish
the indication and efficacy of this technique.
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